Dementia currently affects around 50,000 people in New Zealand, but due to the country’s ageing population, this figure is predicted to triple by 2050. In 2008, the economic cost of dementia was estimated at NZ$712.9 million.
New Zealanders are some of the most anxious people in the world, second only to Americans, according to Te Rau Hinengaro – the New Zealand Mental Health Survey (2006; Wellington: the Ministry of Health).
Anyone who has suffered from insomnia will know what a frustrating and stressful condition it can be. Insomnia literally means ‘without sleep.’ Sleep is essential to health, and being deprived of it can cause many physical and psychological problems.
New drug applications approved by US FDA as of 15 – 31 May 2015 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.